St George’s Hospital, London has just opened a study that is looking at adding an immunotherapy (IMM-101) to nivolumab for advanced melanoma.

The study is enrolling 2 groups of patients – 18 patients who haven’t had treatment for advanced melanoma and 8 patients whose advanced melanoma got worse during previous immunotherapy treatment

Please see https://www.cancerresearchuk.org/about-cancer/find-a-clinical-trial/a-study-of-imm-101-and-nivolumab-for-people-with-advanced-melanoma for further information, contacts and the main entry conditions.

Any patients who need further information, please contact your treating team, or let us know how we can help